Blue Trust Inc. Has $169,000 Stock Position in Centene Co. (NYSE:CNC)

Blue Trust Inc. grew its position in shares of Centene Co. (NYSE:CNCFree Report) by 7.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,454 shares of the company’s stock after acquiring an additional 164 shares during the quarter. Blue Trust Inc.’s holdings in Centene were worth $169,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently modified their holdings of CNC. Coppell Advisory Solutions Corp. bought a new position in Centene in the 4th quarter valued at about $25,000. Operose Advisors LLC bought a new position in shares of Centene in the third quarter valued at approximately $25,000. ST Germain D J Co. Inc. bought a new stake in Centene during the second quarter worth $26,000. OFI Invest Asset Management purchased a new stake in Centene in the 3rd quarter valued at $26,000. Finally, Headinvest LLC bought a new position in Centene during the 3rd quarter valued at $35,000. 93.63% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Centene

In other Centene news, President Kenneth J. Fasola sold 12,000 shares of Centene stock in a transaction dated Wednesday, February 7th. The stock was sold at an average price of $75.07, for a total transaction of $900,840.00. Following the completion of the transaction, the president now owns 235,365 shares of the company’s stock, valued at approximately $17,668,850.55. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In other news, Director Lori Jean Robinson sold 10,000 shares of the business’s stock in a transaction on Tuesday, February 13th. The shares were sold at an average price of $77.41, for a total transaction of $774,100.00. Following the completion of the transaction, the director now directly owns 11,455 shares in the company, valued at approximately $886,731.55. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, President Kenneth J. Fasola sold 12,000 shares of the stock in a transaction on Wednesday, February 7th. The stock was sold at an average price of $75.07, for a total value of $900,840.00. Following the completion of the sale, the president now owns 235,365 shares in the company, valued at approximately $17,668,850.55. The disclosure for this sale can be found here. 0.28% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several brokerages have recently commented on CNC. StockNews.com downgraded shares of Centene from a “strong-buy” rating to a “buy” rating in a report on Thursday, March 28th. Barclays initiated coverage on shares of Centene in a research report on Wednesday, March 6th. They set an “overweight” rating and a $101.00 target price on the stock. UBS Group increased their price target on Centene from $72.00 to $79.00 and gave the company a “neutral” rating in a research report on Thursday, December 21st. Truist Financial upped their price objective on Centene from $83.00 to $86.00 and gave the company a “buy” rating in a research note on Thursday, December 21st. Finally, Wells Fargo & Company boosted their price target on shares of Centene from $90.00 to $94.00 and gave the stock an “overweight” rating in a report on Wednesday, March 20th. Five analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat, Centene currently has an average rating of “Moderate Buy” and a consensus target price of $85.46.

View Our Latest Stock Report on Centene

Centene Price Performance

NYSE CNC opened at $77.75 on Tuesday. The company has a market cap of $41.59 billion, a PE ratio of 15.84, a price-to-earnings-growth ratio of 0.98 and a beta of 0.38. The company has a quick ratio of 1.11, a current ratio of 1.11 and a debt-to-equity ratio of 0.68. The firm’s 50-day simple moving average is $77.25 and its two-hundred day simple moving average is $74.29. Centene Co. has a 52 week low of $60.83 and a 52 week high of $81.42.

Centene (NYSE:CNCGet Free Report) last released its quarterly earnings data on Tuesday, February 6th. The company reported $0.45 earnings per share for the quarter, beating analysts’ consensus estimates of $0.43 by $0.02. The business had revenue of $39.46 billion during the quarter, compared to analyst estimates of $36.16 billion. Centene had a net margin of 1.75% and a return on equity of 14.26%. Centene’s revenue was up 11.0% compared to the same quarter last year. During the same period in the previous year, the business earned $0.86 EPS. Research analysts predict that Centene Co. will post 6.75 earnings per share for the current year.

Centene Profile

(Free Report)

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.

Read More

Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Co. (NYSE:CNCFree Report).

Institutional Ownership by Quarter for Centene (NYSE:CNC)

Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.